Anticomplementary principles of a Chinese multiherb remedy for the treatment and prevention of SARS.

Authors:
Zhang T; Chen D.

Journal:
J Ethnopharmacol

Publication Year: 2008

DOI:
10.1016/j.jep.2008.02.012

PMCID:
PMC7126446

PMID:
18400428

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Ethnopharmacol

Abbreviation: J Ethnopharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Social Sciences

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Comparison study of Beninese and Chinese herbal medicines in treating COVID-19.
Houeze EA; Wang Y; Zhou Q and 2 more (2023) - Transparency Score: 4/6
Chemical profiling and unraveling of anti-COVID-19 biomarkers of red sage (Lantana camara L.) culti…
Darwish RS; El-Banna AA; Ghareeb DA and 3 more (2022) - Transparency Score: 2/6
Efficacy and safety of add-on Viola odorata L. in the treatment of COVID-19: A randomized double-bl…
Adel Mehraban MS; Shirzad M; Mohammad Taghizadeh Kashani L and 5 more (2022) - Transparency Score: 4/6
Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhib…
Zhu Y; Han Q; Wang L and 10 more (2022) - Transparency Score: 4/6
Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB …
Cai J; Wang YL; Sheng XD and 2 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"This work was supported by grant from China Postdoctoral Science Foundation (20060390609). The authors are grateful to Prof. Yunyi Zhang at Fudan University for the helps in bioassay."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025